Today we wish to talk about an interesting case.
A company named HexagonBio who recently raised $61 million to fund its research and growth plan.
Everything is focussed on developing Advance Novel Small-Molecule Medicines Mined from Microbial Genomes.
Read the full article, here. (Link:) https://www.businesswire.com/news/home/20210922005093/en/Hexagon-Bio-Raises-61-Million-to-Advance-Novel-Small-Molecule-Medicines-Mined-from-Microbial-Genomes
This is very good news for us at Naicons.
Our micro4all project is aiming to allow the whole Drug Discovery Process to benefit from a better selected, data endorsed and goal focussed access to Molecules from Microorganisms. It is a complementary and synergistic approach to Hexagon’s.
It is very exciting to read about such a prestigious achievement for a company whose profile and technology is so close to ours.
